ECHiShares MSCI Chile ETF
The schedule
- Thu15Oct
Market pricing of anticipated global tariff adjustments under President Trump, heavily impacting emerging market export expectations.
- Thu12Nov
Q3 earnings cycle for core Chilean equities, reflecting the initial corporate fallout or resilience against late-2026 macro shifts.
- Wed20Jan
Chile releases its final Q4 GDP and annual economic growth figures, summarizing the broader impact of 2026 monetary easing and trade dynamics.
Past
- Wed12Aug
Q2 earnings announcements for ECH's largest portfolio constituents, primarily driven by the financials and materials sectors.
- Thu18Jun
Actual outcome: Bear · $39.13 at outcome
The Banco Central de Chile's monetary policy decision yielded a muted market reaction, with ECH shares slipping 3.2%. Although local inflation showed signs of stabilizing, ongoing volatility in global metal markets likely offset any positive sentiment from the central bank's rate decision, resulting in ambiguous price action that failed to reach either target.
Banco Central de Chile convenes to decide on its benchmark interest rate amid stabilizing local inflation and volatile metal markets.
Scouting Reports
The Passive Tax: How SPGI and NDAQ Monetize Silicon Concentration
Oct 13, 2026
The headline equity benchmark is up 14% this year, yet beneath the surface, more than four in ten S&P 500 constituents are actively underwater. The broader U.S. economy is not necessarily booming; rat
Read more →
The $700B Capex Wall: Testing Tech's Immunity to 5.3% Yields
Oct 6, 2026
Monday's price action delivered a textbook contradiction. The Nasdaq Composite sailed to a record 27,477 and NVDA printed fresh all-time highs, right alongside the 10-year Treasury yield surging past
Read more →
Pricing the Pharma Patent Cliff: The AI Biotech Outsourcing Trade
Aug 25, 2026
The latest breakthrough in personalized cancer treatments isn’t just a win for oncology—it is the opening bell for a massive capital reallocation. Staring down a catastrophic wave of late-2020s patent
Read more →